Public research preview

Lisa McClain, Representative disclosure: Novo Nordisk A/S Common Stock (NVO)

Disclosed a sell transaction in Novo Nordisk A/S Common Stock (NVO). Use this page to inspect source evidence, confidence scores, filing delay, and post-disclosure price movement before deciding whether to research the signal further.

Copy Window
Probably too late
24/100
Signal Quality
42/100
Data quality
93%
High quality

This public page is for public-disclosure research only. It is not investment advice and does not place orders. Verify the official source before relying on any signal.

Evidence passport

Official-source context and parser confidence before any simulation or alert decision.

Source
House STOCK Act disclosures
Published
21 Nov 2025, 00:00
Parser confidence
94%
Instrument mapping
95%
Filing delay
21 days

Timeline

Transaction date

31 Oct 2025

Public disclosure

21 Nov 2025

Now

Tracked today

Filing delay: 21 days

Price movement

Complete coverage

Provider
Yahoo Finance daily close
Fetched
13 Jul 2026

Stock path

NVO from pre-transaction context through latest close.

Transaction

31 Oct 2025 · 47.71 USD · Not public yet

System decision

Would not buyThe strategy's filters reject this signal. Failed filters: Buy disclosure.

Would not buy34.848.261.7USDDate31 Oct21 Nov13 JulOfficial disclosure21 NovTransactionDisclosureLatest
  • Not public yet
  • Would not buy
Observed transaction close
47.71
Observed disclosure close
45.945
Observed latest close
49.275
Pre-disclosure move
-3.7%
Post-disclosure move
+7.2%
Market-adjusted move
-7.5%
1w since disclosure
+3.6%
1m since disclosure
+1.0%
3m since disclosure
+1.7%
Pre-disclosure peak run-up
+1.6%
Retrace from peak
-5.2%

Why Copy Window is Probably too late

Supporting factors

  • Parsed sell disclosure for ordinary shares from House STOCK Act disclosures.
  • Reported amount is $1,001 - $15,000.
  • Post-disclosure move is calculated from Yahoo Finance daily close daily closes.

Cautions

  • Yahoo Finance daily close coverage is end-of-day and should be verified against the official price source.
  • Review the original source document before making any investment decision.

Source document

House STOCK Act disclosures, published 21 Nov 2025, 00:00

View source
Parser confidence
94%
Instrument mapping
95%
FieldExtracted value
roleRepresentative
sidesell
value1001
sourcehouse_stock_act
tickerNVO
chamberHouse
currencyUSD
assetTypestock
sourceUrlhttps://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20033446.pdf
personNameLisa McClain
amountRange$1,001 - $15,000
companyNameNovo Nordisk A/S Common Stock (NVO)
publishedAt2025-11-21T00:00:00.000Z
rawDocumentIdraw-us-house-20033446-301
disclosureDate2025-11-21
transactionDate2025-10-31
transactionTypeS